The first oncogenic fusion detected in lung cancer was EML4–ALK, resulting from a small inversion on the short arm of chromosome 2, that promotes the fusion of EML4 N-terminal with ALK (exon 20) [40]. This evidence concerns the gene ALK and lung cancer.